Kinetic Studies of the Compound I Derivative of CYP119
A R T I C L E S
observed by electron paramagnetic resonance (EPR) and
electron-nuclear double-resonance (ENDOR) spectroscopies
when cryogenic conditions were employed.11,12 A second
protonation on the distal oxygen and loss of water by heterolytic
fragmentation of the O-O bond would give an iron-oxo species
with the iron atom in the formal +5 oxidation state, which is
either a transient perferryloxo species that can relax to a
Compound I derivative or the transition state for the direct
formation of the Compound I derivative. The perferryloxo
species or the Compound I derivative can react in two-electron
oxo-transfer reactions to return the ferric enzyme.
Peroxidase enzymes form Compound I species by reactions
with hydrogen peroxide,7 and P450s also can react with
hydrogen peroxide or other hydroperoxy compounds to give
an active oxidant in what is termed a “shunt” reaction (Figure
1). Fast mixing, stopped-flow mixing, and freeze-quench
mixing experiments with P450s and peroxy species have been
attempted for many years13 with limited success. A short-lived
transient with a calculated spectrum resembling that of CPO
Compound I was detected in reactions of P450cam with m-
chloroperoxybenzoic acid (mCPBA),14,15 but freeze-quench
studies of the same enzyme with either mCPBA or peroxyacetic
acid oxidation employing EPR, ENDOR, and Mo¨ssbauer
spectroscopic analyses indicated that a Compound I derivative
did not accumulate to a detectable level.16-19 Moreover,
production of various iron-oxo transients under “cryoreduction”
conditions suggested that the reaction of the active oxidant in
P450cam with substrate is faster than the rate of formation of
this species, which likely precludes its detection in mixing
studies.11,12 Despite the outcome of attempted P450cam oxida-
tions with mCPBA, reactions of another P450 enzyme, cyto-
chrome P450 119 (CYP119), with mCPBA gave promising
results in that a short-lived transient with a calculated spectrum
similar to that of CPO Compound I was formed;20 these results
are discussed in detail below.
The difficulties in observing a Compound I derivative of a
P450 enzyme in fast-mixing studies prompted us to explore an
alternative entry to these intermediates that has much shorter
temporal resolution than mixing. In principle, photolyses of
iron(IV)-oxo neutral porphyrin complexes, so-called Compound
II derivatives, could give Compound I derivatives by photo-
ejection of an electron from the porphyrin macrocycle, and laser
flash photolysis (LFP) methods with photomultiplier detection
would permit submicrosecond temporal resolution. In practice,
we found that photolyses of Compound II derivatives of a model
Figure 1. Reaction cycles for P450 enzymes. The normal reaction cycle
is shown in black, and the shunt reaction pathway is shown in blue. The
sequence of reactions used to produce Compound I in this work is
highlighted in red. It should be noted that the Compound II derivative is
formulated as a ferrylhydroxy species, on the basis of recent XAS studies
of the CYP119 Compound II species (ref 34).
iron-porphyrin complex, horseradish peroxidase, and myoglo-
bin gave Compound I derivatives.21 Extension of the photo-
oxidation method to the production of a Compound I derivative
of the CYP119 enzyme was subsequently reported in a
communication.22 In the present report, we detail the spectra
and kinetic studies of the CYP119 Compound I derivative.
Results
The enzyme used in this study was CYP119, which was
expressed in Escherichia coli and purified as previously
described.22-24 The CYP119 samples employed were of high
purity, as determined by R/Z values of 1.5 or greater, where
R/Z is the ratio of absorbances at 416 and 280 nm. CYP119
was originally thought to derive from the thermophile Sulfolobus
solfataricus, but a recent study indicated that it came from the
closely related organism Sulfolobus acidocaldarius that con-
taminated an S. solfataricus culture.25
Formation of a Compound II Derivative by Peroxynitrite
Oxidation of CYP119. The photooxidation method for produc-
tion of a Compound I derivative requires that a Compound II
derivative first be produced. The only report of the formation
of a true Compound II derivative of a P450 enzyme prior to
our work was the claim that peroxynitrite (PN) reacted with
cytochrome P450BM3 (CYP102) to give the corresponding
Compound II derivative as a transient and eventually deactivated
the enzyme by nitration of a tyrosine residue.26 Compound II
derivatives of other heme-containing enzymes were known to
be formed by treatment of the resting ferric enzymes with
PN,27-31 and CPO, which is a heme-thiolate enzyme closely
(11) Davydov, R.; Macdonald, I. D. G.; Makris, T. M.; Sligar, S. G.;
Hoffman, B. M. J. Am. Chem. Soc. 1999, 121, 10654–10655.
(12) Davydov, R.; Makris, T. M.; Kofman, V.; Werst, D. E.; Sligar, S. G.;
Hoffman, B. M. J. Am. Chem. Soc. 2001, 123, 1403–1415.
(13) Coon, M. J.; Blake, R. C., II.; Oprian, D. D.; Ballou, D. P. Acta Biol.
Med. Ger. 1979, 38, 449–458.
(14) Egawa, T.; Shimada, H.; Ishimura, Y. Biochem. Biophys. Res.
Commun. 1994, 201, 1464–1469.
(15) Spolitak, T.; Dawson, J. H.; Ballou, D. P. J. Biol. Chem. 2005, 280,
20300–20309.
(21) Zhang, R.; Chandrasena, R. E. P.; Martinez, E., II.; Horner, J. H.;
Newcomb, M. Org. Lett. 2005, 7, 1193–1195.
(16) Schunemann, V.; Jung, C.; Terner, J.; Trautwein, A. X.; Weiss, R.
J. Inorg. Biochem. 2002, 91, 586–596.
(22) Newcomb, M.; Zhang, R.; Chandrasena, R. E. P.; Halgrimson, J. A.;
Horner, J. H.; Makris, T. M.; Sligar, S. G. J. Am. Chem. Soc. 2006,
128, 4580–4581.
(17) Schunemann, V.; Trautwein, A. X.; Jung, C.; Terner, J. Hyperfine
Interact. 2002, 141, 279–284.
(23) McLean, M. A.; Maves, S. A.; Weiss, K. E.; Krepich, S.; Sligar, S. G.
Biochem. Biophys. Res. Commun. 1998, 252, 166–172.
(24) Maves, S. A.; Sligar, S. G. Protein Sci. 2001, 10, 161–168.
(25) Rabe, K. S.; Kiko, K.; Niemeyer, C. M. ChemBioChem 2008, 9, 420–
425.
(18) Schunemann, V.; Lendzian, F.; Jung, C.; Contzen, J.; Barra, A. L.;
Sligar, S. G.; Trautwein, A. X. J. Biol. Chem. 2004, 279, 10919–
10930.
(19) Jung, C.; Schunemann, V.; Lendzian, F.; Trautwein, A. X.; Contzen,
J.; Galander, M.; Bottger, L. H.; Richter, M.; Barra, A. L. Biol. Chem.
2005, 386, 1043–1053.
(26) Daiber, A.; Herold, S.; Scho¨neich, C.; Namgaladze, D.; Peterson, J. A.;
Ullrich, V. Eur. J. Biochem. 2000, 267, 6729–6739.
(27) Floris, R.; Piersma, S. R.; Yang, G.; Johnes, P.; Wever, R. Eur.
J. Biochem. 1993, 215, 767–775.
(20) Kellner, D. G.; Hung, S. C.; Weiss, K. E.; Sligar, S. G. J. Biol. Chem.
2002, 277, 9641–9644.
9
J. AM. CHEM. SOC. VOL. 130, NO. 40, 2008 13311